Share on StockTwits

Shares of CVS Caremark (NYSE:CVS) were the target of unusually large options trading activity on Monday. Traders purchased 7,359 put options on the company, Analyst Ratings.Net reports. This represents an increase of approximately 776% compared to the typical volume of 840 put options.

In other CVS Caremark news, SVP Eva C. Boratto sold 22,107 shares of the company’s stock in a transaction that occurred on Monday, July 21st. The shares were sold at an average price of $76.77, for a total value of $1,697,154.39. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

CVS has been the subject of a number of recent research reports. Analysts at Susquehanna raised their price target on shares of CVS Caremark from $85.00 to $90.00 in a research note on Friday, June 6th. They now have a “positive” rating on the stock. Separately, analysts at Zacks reiterated a “neutral” rating on shares of CVS Caremark in a research note on Thursday, May 29th. They now have a $81.00 price target on the stock. Finally, analysts at Deutsche Bank raised their price target on shares of CVS Caremark from $80.00 to $83.00 in a research note on Wednesday, May 28th. One research analyst has rated the stock with a sell rating, five have issued a hold rating, twelve have given a buy rating and one has issued a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of $77.63.

Shares of CVS Caremark (NYSE:CVS) traded up 1.15% during mid-day trading on Monday, hitting $77.37. 4,396,214 shares of the company’s stock traded hands. CVS Caremark has a 52-week low of $56.32 and a 52-week high of $79.43. The stock has a 50-day moving average of $76.84 and a 200-day moving average of $74.01. The company has a market cap of $90.755 billion and a P/E ratio of 19.48.

CVS Caremark Corporation (NYSE:CVS), together with its subsidiaries, is a pharmacy health care provider in the United States.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.